Lonza: To Establish Strategic Biomanufacturing Base In China Using GE Healthcare Solution.

10 Dec 2018 14:03

New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages. GE Healthcare's off-the-shelf biologics factory, KUBio, will provide the base for GMP manufacturing. Memorandum of understanding to be signed with Guangzhou Development District for leasing of the 17,000m2 site...

Attachments: